4,4,5,5-tetramethyl-2-(4-(3-methyloxetan-3-yl)phenyl)-1,3,2-dioxaborolane

Catalog No. :
ACFKNJ623
CAS No. :
1453860-99-5
Molecular Formula :
C16H23BO3
Molecular Weight :
274.17

IUPAC Name:4,4,5,5-tetramethyl-2-(4-(3-methyloxetan-3-yl)phenyl)-1,3,2-dioxaborolane

4,4,5,5-tetramethyl-2-(4-(3-methyloxetan-3-yl)phenyl)-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$825.00Login to see priceIn stockInquiry
250mg95%$1320.00Login to see priceIn stockInquiry
500mg95%$2200.00Login to see priceIn stockInquiry
1g95%$3299.00Login to see priceIn stockInquiry
5g95%$9895.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4,5,5-tetramethyl-2-(4-(3-methyloxetan-3-yl)phenyl)-1,3,2-dioxaborolane
IUPAC Name4,4,5,5-tetramethyl-2-(4-(3-methyloxetan-3-yl)phenyl)-1,3,2-dioxaborolane
Molecular FormulaC16H23BO3
Molecular Weight274.17
SMILESCC1(C2=CC=C(B3OC(C)(C)C(C)(C)O3)C=C2)COC1
InChI KeyHVZJSKWSPAFLGM-UHFFFAOYSA-N
Synonym4,4,5,5-Tetramethyl-2-[4-(3-methyl-3-oxetanyl)phenyl]-1,3,2-dioxaborolane;4,4,5,5-tetramethyl-2-[4-(3-methyloxetan-3-yl)phenyl]-1,3,2-dioxaborolane
CAS No.1453860-99-5

Synthetic Route by SureRoute

1. ACFKNJ623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACIDQA925 route compound structure diagram
    ACIDQA925872882-97-8 In Stock
  4. Then
  5. ACFKNJ623 route product structure diagram
    ACFKNJ6231453860-99-5 In Stock
Inquiry

2. ACFKNJ623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFKNJ623 route product structure diagram
    ACFKNJ6231453860-99-5 In Stock
Inquiry

Comments (0)